All Insights
Exploring the science, practice, and business of medicine.
Exploring the science, practice, and business of medicine.
Showing 10 out of 541 Insights
Informed consent is an evolving, trust-building partnership between researchers and participants—one that goes far beyond a signature to ensure true understanding, respect autonomy, and navigate the growing ethical and technological complexities of modern clinical studies.
In this Harvard Macy Institute blog post, two common learning myths—learning styles and multitasking—are discussed.
HealthSpark, Episode 15: Yuri Quintana, Chief of the Division of Clinical Informatics at Beth Israel Deaconess Medical Center and Assistant Professor of Medicine at Harvard Medical School, who has spent decades designing digital health and AI solutions, explores how these ecosystems can help support health systems deliver better outcomes with limited resources.
As the latest technology transforms how care is delivered, leaders need the capabilities to navigate this moment with clarity and confidence.
Turning evidence into impact requires more than rigorous research—it demands leaders who design studies for real-world implementation, align stakeholders, and bridge the persistent gap between what works in theory and what transforms care in practice.
HealthSpark, Episode 14: Tisha Boatman, Executive Vice President of External Affairs at Siemens Healthineers, explores how strategic decisions in health technology and delivery can transform markets and patient lives by expanding sustainable access to high-quality care around the world.
MedEdPearls June 2026: Wise Compassion and the Clinical Narrative
HealthSpark, Episode 13: Sandhya Rao, Chief Medical Officer and Senior Vice President at Blue Cross Blue Shield of Massachusetts and a practicing primary care physician, explores how innovative care models, thoughtful benefit design, and real-world implementation challenges intersect in the effort to expand access to high-quality and affordable mental health care.
HealthSpark, Episode 12: Rushdy Ahmad, Director of the Wyss Diagnostics Accelerator at Harvard's Wyss Institute, explores how biomarker-driven diagnostics can transform critical unmet needs into groundbreaking tools that reach patients around the world.
MedEdPearls May 2026: Cultivating an Intentional, Evidence‑Driven Culture of Interprofessional Learning